SPDR® S&P 600 Small Cap Growth ETF

Most Recent

  • uploads///Sucampo Revenue Growth
    Company & Industry Overviews

    Key Risks Facing Sucampo Pharmaceuticals in 2017

    Sucampo has taken on a significant level of debt. Its outstanding debt is ~$300 million. Its interest expense has increased from $6.8 million in 2015 to $23.7 million in 2016.

    By Kenneth Smith
  • uploads///Graph
    Company & Industry Overviews

    Promacta: A Major Growth Driver for Ligand Pharmaceuticals in 2017

    Promacta was discovered by Ligand Pharmaceuticals (LGND) and GlaxoSmithKline (GSK) as a part of their thrombopoietin (or TPO) receptor agonist research collaboration.

    By Margaret Patrick
  • uploads///Stock Performance of Cal Maine Foods and Peers
    Consumer

    How Did Cal-Maine Foods Stock React to Its Fiscal 4Q16 Results?

    Cal-Maine Foods reported its fiscal 4Q16 results on July 18. There wasn’t impact on the stock price even though the company reported a loss for the quarter.

    By Sushree Mohanty
  • uploads///Cal Maines and Peers Dividend Yield
    Consumer

    How Much Did Cal-Maine Return to Shareholders in Fiscal 2016?

    Cal-Maine Foods has a dividend yield of 4.0% as of July 18, 2016. Management raised the dividend at a CAGR (compound annual growth rate) of 15.3% over five years.

    By Sushree Mohanty
  • uploads///dividend
    Miscellaneous

    Analyzing Cal-Maine Foods’ Variable Dividend Policy

    Cal-Maine has a variable dividend policy in place. It has a dividend yield of 5.8% as of June 28. Management raised the dividend at a CAGR of 15.3% over five years.

    By Sushree Mohanty
  • uploads///BG Foods Revised EPS Estimates
    Miscellaneous

    Analysts Have Revised EPS Estimates for B&G Foods: Why?

    B&G Foods’ (BGS) earnings estimates have been on an upward trend since its fiscal 1Q16 impressive results. The Green Giant acquisition contributed to the results.

    By Sushree Mohanty
  • uploads///BG Foods Stock Performance against Benchmark ETF
    Earnings Report

    Why Did B&G Foods Stock Fall 10% after Fiscal 4Q15 Results?

    With 4Q15 earnings below estimates by 12% and lower-than-expected guidance for 2016, BGS stock fell 10% the next day.

    By Sushree Mohanty
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.